Zymo Research Corp Revenue and Competitors
Estimated Revenue & Valuation
- Zymo Research Corp's estimated annual revenue is currently $35.5M per year.
- Zymo Research Corp's estimated revenue per employee is $155,000
Employee Data
- Zymo Research Corp has 229 Employees.
- Zymo Research Corp grew their employee count by 9% last year.
Zymo Research Corp's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Corporate Development | Reveal Email/Phone |
2 | Controller | Reveal Email/Phone |
3 | Services Director | Reveal Email/Phone |
4 | Director Nucleic Acid Products | Reveal Email/Phone |
5 | Director Informatics | Reveal Email/Phone |
6 | Director Applied Epigenetics | Reveal Email/Phone |
7 | Technical Support Manager | Reveal Email/Phone |
8 | Software Engineering Manager | Reveal Email/Phone |
9 | AP/AR Manager | Reveal Email/Phone |
10 | Supply Chain Manager | Reveal Email/Phone |
Zymo Research Corp Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Zymo Research Corp?
Since its inception in 1994, Zymo Research has been proudly serving the scientific community by providing innovative, reliable, and high quality research tools at affordable prices. Our vision..."The Beauty of Science is to Make Things Simple" is now truer than ever. Whether it's epigenetics, DNA, RNA, E. coli, or yeast based research, our philosophy remains the same: To provide the highest quality products in the industry while ensuring they are both simple to use and reliable in their performance. Zymo Research is historically recognized for its innovation of high quality nucleic acid purification technologies. Under the branding DNA Purification Made Simple and RNA Purification Made Simple, our technologies are pushing the limits of what is possible with nucleic acid isolation. As The Epigenetics Company, Zymo Research has also received much attention for its rapidly expanding portfolio of epigenetics products and services. It is our objective to develop and provide the most comprehensive set of tools for DNA, RNA, and epigenetic research and analysis available today. Thousands of peer-reviewed scientific publications from researchers around the world feature our technologies. Through innovation, our scientists have made streamlined DNA methylation detection possible, pioneered the micro-elution column for DNA and RNA purification, developed the simplest and the most sophisticated methods for high-quality plasmid DNA purification, and patented the first RNA purification directly from Trizol without phase separation among many other leading technologies in the industry. At Zymo Research, we are committed to quality and guarantee that all of our products and service will meet and exceed your expectations. We pledge to be honest and responsible for everything we do with you. We will treat you as we would like to be treated. Together, we will build a brighter future.
keywords:N/AN/A
Total Funding
229
Number of Employees
$35.5M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Zymo Research Corp News
... biomedical technology company based in Singapore. The investment allows Zymo Research and Star Array to combine Zymo Research's nucleic...
... Bio-Rad, New England Biolabs, Agilent, Qiagen, Zymo Research ... The Epigenetics Market study also provides company biographies,...
About Zymo Research Corp. Zymo Research is a privately owned company that has been serving the scientific and diagnostics community with state-...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $76.2M | 230 | -7% | N/A |
#2 | $51.3M | 231 | 5% | N/A |
#3 | $35.6M | 231 | N/A | N/A |
#4 | $73.7M | 231 | 5% | N/A |
#5 | $25.4M | 231 | 0% | N/A |